WPD Pharmaceuticals Inc. (CSE:WBIO)
Canada · Delayed Price · Currency is CAD 0.0700
-0.1200 (-63.16%)
Feb 20, 2025, 6:23 PM EDT
WPD Pharmaceuticals Company Description
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
WPD Pharmaceuticals Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Mariusz Olejniczak |
Contact Details
Address: 700 – 595 Burrard Street Vancouver, British Columbia V7X 1S8 Canada | |
| Website | wpdpharmaceuticals.com |
Stock Details
| Ticker Symbol | WBIO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA92941F1053 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mariusz Olejniczak | Chief Executive Officer |
| Dr. Katarzyna Suchoszek Ph.D. | Director f Operations |
| Beata Pajak Eng., Ph.D. | Chief Scientific Officer |
| Marek Sipowicz M.D., Ph.D. | Chief Medical Officer |